ARF4 and cervical carcinoma: Our results also demonstrated that increased expression of ARF4, BSG, and HSP90 was significantly associated with shorter overall survival time in cervical cancer patients (Figure 5), suggesting that these genes might act as oncogenes in cervical cancer, and serve as potential biomarkers for predicting the prognosis of cervical cancer patients.